About Us
About AJMC
About AJPB
Publications
AJMC
AJPB
Evidence-Based Diabetes Management
Evidence-Based Oncology
Supplements
Subscribe for FREE
AJMC TV
Interviews
Peer Exchange
Interactive
Interactive Tools
Featured Podcasts
Conferences
ACC 2013
AJMC Live Meeting - Oncology
AES2012
AHIP 2012
AHIP 2012 Fall Forum
AHIP Medicare Medicaid
AMCP Fall 2012
AMCP Spring 2013
ADA 2012
ASH 2012
CHEST 2012
Joslin Diabetes Innovation
NAMCP 2012
NAMCP Spring 2013
SCAI 2013
ATS 2013
News
Info for Authors
Information for Authors
Call for Papers
Submit / Track a Manuscript
Authorship Forms
Information for Reviewers
Resource Centers
Acute Coronary Syndrome
Biosimilars
Care Management
Diabetes
Evidence-Based Oncology
Pain
Value-Based Cardiology
Value-Based Insurance Design
Advertisement
FEATURED PODCASTS
Dr. Lichter Discusses the Growing Concern for the Future of Oncology Practice if the SGR is Not Fixed
Dr. Lichter Addresses the Need to Update the Fee-for-Service Methodology That Awards High Quality and Cost Effective Care
Dr. Lichter Explains ASCOs Idea of Using Its Quality Oncology Practice Initiative (QOPI) as a Solution to the SGR
Dr. Lichter Discusses the Need for CMS to Run Pilot Programs to Create Well Crafted Solutions to the SGR
Dr. Lichter Discusses the Proposed Solutions to the Sustainable Growth Rate (SGR)
Interview with Dan Hawkins, SVP for Policy and Programs at the National Association of Community Health Centers: Part 2
Mr. Dan Hawkins talks about areas in the United States that have unmet needs for community health centers.
Interview with Dan Hawkins, SVP for Policy and Programs at the National Association of Community Health Centers: Part 1
Mr. Dan Hawkins discusses the National Association of Community Health Center's “Access Endangered” report.
Interview with Dr. Michael Link, ASCO President: Part 3
Interview with Dr. Michael Link, ASCO President: Part 2
Dr. Michael Link talks about specific drugs in short supply and the effect on patients.
Interview with Dr. Michael Link, ASCO President: Part 1
Dr. Michael Link discusses the impact of drug shortages.
Advertisement
Advertisement